Professional Documents
Culture Documents
“Neuroalimentación”
Barcelona, 29 y 30 Septiembre de 2018
Fernando Gómez-Pinilla
Departments of Neurosurgery and Physiological Science, University of California at Los Angeles
School of Medicine, Los Angeles 90095, California, USA
Fernando Gómez-Pinilla: fgomezpi@mednet.ucla.edu
Abstract
En positivo.....
It has long been suspected that the relative abundance of specific nutrients can affect cognitive
processes and emotions. Newly described influences of dietary factors on neuronal function and
synaptic plasticity have revealed some of the vital mechanisms that are responsible for the action of
diet on brain health and mental function. Several gut hormones that can enter the brain, or that are
produced in the brain itself, influence cognitive ability. In addition, well-established regulators of
synaptic plasticity, such as brain-derived neurotrophic factor, can function as metabolic modulators,
responding to peripheral signals such as food intake. Understanding the molecular basis of the effects
of food on cognition will help us to determine how best to manipulate diet in order to increase the
Dra. Maria J. López Juez
Neurobiologa
resistance of neurons to insults and promote mental fitness.
HHS Public Access
Author manuscript
Dev Psychopathol. Author manuscript; available in PMC 2016 May 01.
Published in final edited form as:
Dev Psychopathol. 2015 May ; 27(2): 411–423. doi:10.1017/S0954579415000061.
Abstract
The human brain undergoes a remarkable transformation during fetal life and the first postnatal
years from a relatively undifferentiated but pluripotent organ to a highly specified and organized
one. The outcome of this developmental maturation is highly dependent on a sequence of
Dra. Maria J. López Juez
environmental exposures that can have either positive or negative influences on the ultimate
Neurobiologa
plasticity of the adult brain. Many environmental exposures are beyond the control of the
Nutrition Research Reviews (2014), 27, 199–214 doi:10.1017/S0954422414000110
q The Authors 2014
Abstract
Autism spectrum disorder (ASD) is characterised by deficits in the ability to socialise, communicate and use imagination, and displays of
stereotypical behaviour. It is widely accepted that ASD involves a disorder in brain development. However, the real causes of the neu-
rodevelopmental disorders associated with ASD are not clear. In this respect, it has been found that a majority of children with ASD
display gastrointestinal symptoms, and an increased intestinal permeability. Moreover, large differences in microbiotic composition
“ ......y en negativo”
between ASD patients and controls have been reported. Therefore, nutrition-related factors have been hypothesised to play a causal
role in the aetiology of ASD and its symptoms. Through a review of the literature, it was found that abnormalities in carbohydrate diges-
esearch Reviews
tion and absorption could explain some of the gastrointestinal problems observed in a subset of ASD patients, although their role in the
neurological and behavioural problems remains uncertain. In addition, the relationship between an improved gut health and a reduction
of symptoms in some patients was evaluated. Recent trials involving gluten-free diets, casein-free diets, and pre- and probiotic, and
multivitamin supplementation show contradictive but promising results. It can be concluded that nutrition and other environmental
influences might trigger an unstable base of genetic predisposition, which may lead to the development of autism, at least in a
subset of ASD patients. Clear directions for further research to improve diagnosis and treatment for the different subsets of the disorder
are provided.
Dra. Maria J. López Juez
Neurobiologa
Key words: Autism spectrum disorder: Treatment: Diagnosis: Gluten-free diets: Gut – brain axis
Efectos de la alimentación en la cognición
Entrada
Sistema limbico
sensorial
Hipotálamo
Simpatico/Parasimpatico
Troncoencefalo
Fisiologia del organismo
caudal
Sintesis de moleculas
Serotonina
Nervio vago Dopamina
Alimentación Histamina
Intestino
Insulina, Leptina, etc
PubMed Central, Figure 1: Nat Rev Neurosci. Jul 2008; 9(7): 568–578. doi: 10.1038/nrn2421
Dra. Maria J. López Juez
Neurobiologa
El eje intestino-cerebro
S.N.C. S.N.E.
1º Cerebro 2º Cerebro
Sin embargo....
están aumentando.
40
32,8%
30
18,1%
20
10
0
Mexico EEUU Argentina R.Checa Malta Australia Reuino Unido España
¿Que ha cambiado?
✓El entorno
✓La dieta del mundo occidental
✓Fármacos disponibles
Hipocrates
Microbiota Disbiosis
sana intestinal
Y que mas.....?
NEUROCIENCIA
✓ Macronutrientes:
Hidratos de carbono
Proteínas
Grasas
✓ Micronutrientes:
Vitaminas
Minerales
✓ Agua
✓ Fibra
!Ingestión
!Digestión
!Absorción
!Transporte
!Transformación de los alimentos.
Alergias
Alimentos
alimentarias
refinados
Consumo de energia:
SNC: constituye 2% en peso del organismo
Consume: 20% de la energia
1/5 del Oxigeno que llega a nuestro organismo
Vitaminas
Omega 3
Minerales
Nutrientes
Aminoácidos
Antioxidantes
Neuropharmacology
journal homepage: www.elsevier.com/locate/neuropharm
Invited review
a r t i c l e i n f o a b s t r a c t
An Pediatr (Barc). 2010;73(3):142.e1–142.e8
Article history: Omega-(n)-3 polyunsaturated fatty acids (PUFAs), including docosahexaenoic acid (DHA) and eicosa-
Received 1 April 2012 pentaenoic acid (EPA) are major components of neuronal membranes and have a wide range of functions,
Received in revised form from modulating synaptic plasticity and neurochemistry, to neuroimmune-modulation and neuro-
6 July 2012
protection. Thus, it is not surprising that n-3 PUFA are widely acknowledged to have cognitive-enhancing
Accepted 8 July 2012
effects. Although clinical evidence is somewhat conflicting, probably in large part due to methodological
issues, animal studies have consistently demonstrated that n-3 PUFA are indispensable for proper brain
Keywords:
development, may enhance cognitive function in healthy, adult individuals and attenuate cognitive
Polyunsaturated fatty acids
Docosahexaenoic acid
impairment in aging and age-related disorders, such as dementia. This review discusses and integrates
Eicosapentaenoic acid up to date evidence from clinical and animal studies investigating the cognitive-enhancing effects of n-3
Cognition PUFA during development, child- and adult-hood, as well as old-age with associated neurodegenerative
Development
www.elsevier.es/anpediatr
diseases, such as Alzheimer’s disease. Furthermore, we cover the major underlying biochemical and
Dementia neurophysiological mechanisms by which n-3 PUFA mediate these effects on cognition.
This article is part of a Special Issue entitled ‘Cognitive Enhancers’.
! 2012 Elsevier Ltd. All rights reserved.
y recomendaciones
The global para suofPUFA
health burden of human mental and neurological ingesta en lasupported infancia
brain function that has been extensively studied in relation to n-3
is cognition. Although by somewhat conflicting
disorders has surpassed that of both cardiovascular disease and clinical evidence, it is thought that deficiency of n-3 PUFA has
cancer (Collins et al., 2011). At the same time, the availability of detrimental effects on cognitive brain development, while
M. Gil-Campos, J. Dalmau Serra! y Comité de Nutrición de la Asociación Española de
omega-(n)-3 polyunsaturated fatty acids (PUFAs) in the Western
diet has dramatically decreased during the last several decades
conversely, the dietary supplementation of n-3 PUFA may be
beneficial (Karr et al., 2011). Furthermore, evidence from clinical
~
Pediatrı́a
(Bazan et al., 2011). Increasing evidence has linked deficiency in and animal studies suggests that n-3 PUFA may have therapeutic
dietary intake of n-3 PUFAs to the burden of human mental and value for cognitive impairment associated with normal aging and
neurological disorders (Zhang et al., 2011) but the role of these neurodegenerative disorders such as Alzheimer’s disease (AD)
Recibido el 7 de marzo de 2010; aceptado el 8 de marzo de 2010et al., 2011; Karr et al., 2011). With the increasing age of
(Zhang
Western population and rise of neurodegenerative disorders, there
Dra. Maria J. LópezDisponible
Juez en Internet el 8 de junio de 2010
is an urgent need for effective, mild therapy to prevent, delay or
Neurobiologa Abbreviations: PUFAs, Polyunsaturated fatty acids; n-3, omega-3; n-6, omega-6;
cure these disorders. Thus, it is timely, to determine whether the
LA, C18:2, n-6: linoleic-acid; AA, C20:4, n-6: arachidonic acid; DPA, C22:5, n-6:
Docosapentaenoic acid; ALA, C18:3, n-3: Alpha-linolenic acid; EPA, C20:5, n3: claimed benefits of otherwise safe and side-effect free n-3 PUFA can
Docosahexaenoic acid supplementation increases prefrontal cortex activation during sustained attention in
healthy boys: a placebo-controlled, dose-ranging, functional magnetic resonance imaging study. Robert K
McNamara et all Am J Clin Nutr 2010;91:1060–7. Printed in USA. ! 2010 American Society for Nutrition
1064 MCNAMARA ET AL
TABLE 2 TABLE 3
Performance measures on the identical-pairs continuous performance task1 Regions exhibiting differential activation during sustained attention1
400 mg 1200 mg P P Talairach
Placebo DHA/d DHA/d value2 value3 coordinates Cluster
extent
Baseline Brain region (Brodmann’s area) x y z (voxels)
ON BRAIN ACTIVATION Percentage correct 0.8 6 0.2 0.8 61063
0.2 0.9 6 0.1 0.17 —
Discriminability 0.9 6 0.0 0.9 6 0.0 0.9 6 0.0 0.18 — mm
Commission errors 2.1 6 1.7 1.4 6 1.3 1.7 6 1.6 0.61 — Placebo versus low dose
Reaction time (ms) 692 6 83 652 6 50 655 6 48 0.29 — DHA . placebo
Endpoint Right inferior frontal gyrus (BA9) 44 23 26 445
Percentage correct 0.8 6 0.1 0.8 6 0.1 0.8 6 0.1 0.71 0.68 Right precentral gyrus (BA6) 36 210 30
Discriminability 0.9 6 0.0 0.9 6 0.0 0.9 6 0.0 0.73 0.18 Placebo . DHA
e2 Commission errors 2.3 6 1.7 2.6 6 1.7 2.1 6 2.1 0.81 0.64 Right occipital lobe, lingual gyrus (BA17) 14 287 3 275
Reaction time (ms) 695 6 94 641 6 59 652 6 39 0.18 0.64 22 289 22
2 1 Left occipital lobe, lingual gyrus (BA17) 28 290 24
All values are means 6 SDs. DHA, docosahexaenoic acid.
2
One-factor ANOVA.
Placebo versus high dose
3
Two-factor ANOVA (treatment phase · dose interaction).
DHA . placebo
Left superior frontal gyrus (BA9) 220 48 36 288
226 44 29
6 percentage correct, commission errors, discriminability, or re- Placebo . DHA
4 action time. The time · dose interaction was not significant for Right cerebellum, posterior lobe 8 281 221 382
percentage correct, commission errors, discriminability, or re- Left cerebellum, posterior lobe 28 283 223
6 210 282 235
action time. Among all subjects (n = 33), erythrocyte DHA
0 composition was inversely correlated with reaction time at Low dose versus high dose
4 High . low
baseline (r = 20.43, P = 0.01) and endpoint (r = 20.41, P =
Left parietal lobe (BA43) 261 29 17 358
2 0.02), but was not correlated with other performance measures. Left temporal lobe (BA42) 259 29 10
251 221 1
3 Right occipital lobe (BA30) 26 271 9 278
6 fMRI Right posterior cingulate (BA31) 26 261 14
Right cerebellum, posterior lobe 8 277 220 1091
Between baseline and endpoint, the subjects treated with low- 30 263 220
est dose DHA had greater increases in activation of the right DLPFC Left cerebellum, posterior lobe 222 269 220
(BA9) and precentral gyrus (BA6) and greater decreases in ac- 1
DHA, docosahexaenoic acid. Only comparisons that were significant
tivation of bilateral occipital cortex (BA17) relative to the pla-
at P , 0.05 (corrected) are included in the table. Larger voxel clusters
cebo group (Table 3, Figure 2). No additional regions were required more than one set of coordinates.
identified as having greater increases in activation based on a
less-stringent voxel-extent threshold (T ! 100), whereas greater
ee Dra. Maria J. López Juez decreases in activation were observed in the left para- and cingulate gyrus (BA23,24), and there were no significant
Neurobiologa hippocampal gyrus (BA35,36, T140), right temporal lobe negative correlations.
ne (BA20, T137), and right cerebellum (anterior lobe, T176). Be-
nt
Dietas para niños ¿Qué incluir?
Colorantes
Excitantes
Conservantes
Drogas
✓Cereales
✓Legumbres
✓Frutas
✓Verduras
✓Dulces
Micronutrientes
minerales, aminoacidos que no son bien asimilados
Del Bioscreening® resulta que Ud. no asimila correctamente algunos
e algunas vitaminas; resulta tambièn una
intolerancia hacia ciertos alimentos,colorantes, conservantes,
productos de sintesis y metales toxicos.
Intolerancias
Del Bioscreening®aresulta
alimentos
una intolerancia hacia ciertos alimentos,
colorantes, conservantes, productos de sintesis y metales toxicos.
✓Diseño de la dieta
✓Suplementos individualizados
www.neocortex.es